UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June, 2013.
Commission File Number ________________
Novogen Limited
(Translation of registrant’s name into English)
1-7 Waterloo Road, Macquarie Park, NSW, Australia
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
| Form 20-F x Form 40-F o |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Indicate by check mark if the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes o No x
If “yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Novogen Limited (Registrant)
(Signature) *
Andrew Bursill
Date 3 June 2013
* Print the name and title under the signature of the signing officer.
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity NOVOGEN LIMITED
ABN
37 063 259 754
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
Graham Kelly
Date of last notice
18 February 2013
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Indirect
Nature of indirect interest
i.
Bende Holdings Pty Ltd – controlled
(including registered holder)
entity
Note: Provide details of the circumstances giving rise to the relevant
interest.
ii.
Coolawin Rd Pty Ltd – controlled
entity
iii.
Coolawin Rd Super Fund– controlled
entity
iv.
Phytose Corporation Pty Ltd –
controlled entity
Date of change
28 May 2013
No. of securities held prior to change
i.
Bende Holdings Pty Ltd
1,677,343 ordinary shares
ii.
Coolawin Rd Pty Ltd
503,300 ordinary shares
iii.
Coolawin Rd Super Fund
10,354 ordinary shares
iv.
Phytose Corporation Pty Ltd
1,694,795 ordinary shares
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
Class
Ordinary Shares
Number acquired
Phytose Corporation Pty Ltd
29,412 ordinary shares
Number disposed
N/A
Value/Consideration
$0.17 per share (total consideration $5,000)
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change
i.
Bende Holdings Pty Ltd
1,677,343 ordinary shares
ii.
Coolawin Rd Pty Ltd
503,300 ordinary shares
iii.
Coolawin Rd Super Fund
10,354 ordinary shares
iv.
Phytose Corporation Pty Ltd
1,724,207 ordinary shares
Nature of change
Example: on-market trade, off-market trade, exercise of options, Participation in share purchase plan.
issue of securities under dividend reinvestment plan, participation in
buy-back
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
N/A
(if issued securities)
Date of change
N/A
No. and class of securities to which interest N/A
related prior to change
Note: Details are only required for a contract in relation to which the
interest has changed
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y
Change of Director’s Interest Notice
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
N/A
Note: If consideration is non-cash, provide details and an estimated
valuation
Interest after change
N/A
Part 3 – +Closed period
Were the interests in the securities or contracts No
detailed above traded during a +closed period
where prior written clearance was required?
If so, was prior written clearance provided to allow N/A
the trade to proceed during this period?
If prior written clearance was provided, on what N/A
date was this provided?
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity NOVOGEN LIMITED
ABN
37 063 259 754
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
Robert Howard Birch
Date of last notice
18 February 2013
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Direct
Indirect – Aquagolf Pty Limited <Aquagolf
Pty Ltd Superannuation Fund A/c>
Nature of indirect interest
(including registered holder)
Controlled entity
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change
N/A
No. of securities held prior to change
Direct
36,750 Ordinary Shares
Aquagolf Pty Limited <Aquagolf Pty
Ltd S/F A/c>
1,497,136 Ordinary Shares
Class
Ordinary Shares
Number acquired
88,236 ordinary shares
Number disposed
N/A
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
Value/Consideration
$0.17 per share (total consideration
Note: If consideration is non-cash, provide details and estimated
valuation
$15,000)
No. of securities held after change
Direct
124,986 Ordinary Shares
Aquagolf Pty Limited <Aquagolf Pty
Ltd S/F A/c>
1,497,136 Ordinary Shares
Nature of change
As part of share purchase plan
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
N/A
(if issued securities)
Date of change
N/A
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
N/A
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y
Change of Director’s Interest Notice
Part 3 – +Closed period
Were the interests in the securities or contracts detailed No
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade N/A
to proceed during this period?
If prior written clearance was provided, on what date was this N/A
provided?
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity NOVOGEN LIMITED
ABN
37 063 259 754
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
Steven Coffey
Date of last notice
8 November 2012
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Indirect
Nature of indirect interest
(including registered holder)
Steven Roy Coffey Superannuation Fund
Note: Provide details of the circumstances giving rise to the relevant
interest.
(Steven and Sandra Coffey as trustee)
Date of change
28 May 2013
No. of securities held prior to change
Indirect
1,000 ordinary shares
Class
Ordinary Shares
Number acquired
88,236 ordinary shares
Number disposed
N/A
Value/Consideration
$0.17 per share (total consideration $15,000)
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change
Indirect
89,236 ordinary shares
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
Nature of change
Participation in share purchase plan.
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
N/A
(if issued securities)
Date of change
N/A
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
N/A
Part 3 – +Closed period
Were the interests in the securities or contracts detailed No
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade N/A
to proceed during this period?
If prior written clearance was provided, on what date was this N/A
provided?
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity NOVOGEN LIMITED
ABN
37 063 259 754
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
John O’Connor
Date of last notice
30 May 2012
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Direct
Indirect
Nature of indirect interest
(including registered holder)
Aspargo Pty Ltd – ATF Aspargo
Note: Provide details of the circumstances giving rise to the relevant
interest.
Superannuation Fund
Date of change
28 May 2013
No. of securities held prior to change
Direct
20,530 ordinary shares
Indirect
233,071 ordinary shares
Class
Ordinary Shares
Number acquired
25,000 ordinary shares
Number disposed
N/A
Value/Consideration
$0.17 per share (total consideration $4,250)
Note: If consideration is non-cash, provide details and estimated
valuation
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
No. of securities held after change
Direct
20,530 ordinary shares
Indirect
258,071 ordinary shares
Nature of change
Participation in share purchase plan.
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
N/A
(if issued securities)
Date of change
N/A
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
N/A
Part 3 – +Closed period
Were the interests in the securities or contracts detailed No
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade N/A
to proceed during this period?
If prior written clearance was provided, on what date was this N/A
provided?
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011